ğŸ§¬ GENE OF THE WEEK: HBB

The hemoglobin gene. HBB mutations cause sickle cell disease and beta-thalassemiaâ€”among the most common genetic disorders worldwide.

Key Conditions:

ğŸ©¸ Sickle Cell Disease
HbS mutation (E6V). Red cells become rigid, sickle-shaped. Causes vaso-occlusive crises, anemia, organ damage. Most common in African descent.

ğŸ©¸ Sickle Cell Trait
One HbS allele (carrier). Usually asymptomatic. Provides malaria protection.

ğŸ©¸ Beta-Thalassemia Major
Two severe mutations. Little/no beta-globin. Requires lifelong transfusions. Mediterranean, Middle East, Asian populations.

ğŸ©¸ Beta-Thalassemia Minor
One mutation (carrier/trait). Mild microcytic anemia. Often mistaken for iron deficiency.

Carrier Screening Critical:

If both parents carry HBB mutations:
â†’ 25% chance of affected child

Treatment Advances:

ğŸ§¬ Gene therapy (Casgevy) now FDA-approved for sickle cell
ğŸ’Š Hydroxyurea
ğŸ©¸ Transfusions
ğŸ¦´ Bone marrow transplant

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#GeneOfTheWeek #HBB #SickleCell #Thalassemia #Bioscope
